Skip to main content

Table 6 BMD changes after hormone therapy in relation to the rs9340799 and rs2234693 genotypes

From: The estrogen receptor 1 gene affects bone mineral density and osteoporosis treatment efficiency in Slovak postmenopausal women

Genotypes

Skeletal site

BMD before treatment

BMD after treatment

BMD difference after treatment

GLM Sig. (P value)

PC Sig. (P value)

rs9340799:A > G genotypes

GG

FN T-score

−2.108 ± 0.106

−1.500 ± 0.082

0.608 ± 0.090

0.001

 

FN BMD

0.605 ± 0.013

0.678 ± 0.010

0.073 ± 0.011 (+ 12.6%)

0.001

 

AG

FN T-score

−2.138 ± 0.063

−1.738 ± 0.049

0.400 ± 0.061

0.001

 

FN BMD

0.601 ± 0.008

0.649 ± 0.006

0.048 ± 0.007 (+ 8.4%)

0.001

 

AA

FN T-score

−2.141 ± 0.082

−1.991 ± 0.063

0.150 ± 0.066

0.035

 

FN BMD

0.601 ± 0.010

0.619 ± 0.008

0.018 ± 0.008 (+ 3.4%)

0.035

 

GG-AG

FN T-score

  

0.134 ± 0.952

0.042 for FN T-score and FN BMD

NS

FN BMD

  

0.016 ± 0.011

NS

GG-AA

FN T-score

  

0.262 ± 0.103

0.035

FN BMD

  

0.031 ± 0.012

0.035

AG-AA

FN T-score

  

0.128 ± 0.795

NS

FN BMD

  

0.015 ± 0.010

NS

GG

LS T-score

−2.877 ± 0.109

−1.823 ± 0.094

1.054 ± 0.053

0.001

 

LS BMD

0.675 ± 0.012

0.788 ± 0.010

0.113 ± 0.006 (+ 16.9%)

0.001

 

AG

LS T-score

−2.843 ± 0.064

− 2.105 ± 0.056

0.738 ± 0.073

0.001

 

LS BMD

0.679 ± 0.007

0.758 ± 0.006

0.079 ± 0.008 (+ 11.9%)

0.001

 

AA

LS T-score

−2.932 ± 0.083

− 2.459 ± 0.073

0.473 ± 0.125

0.001

 

LS BMD

0.669 ± 0.009

0.720 ± 0.008

0.051 ± 0.013 (+ 8.3%)

0.001

 

GG-AG

LS T-score

  

0.124 ± 0.092

0.002 for FN T-score and FN BMD

NS

LS BMD

  

0.013 ± 0.010

NS

GG-AA

LS T-score

  

0.345 ± 0.100

0.003

LS BMD

  

0.037 ± 0.011

0.003

AG-AA

LS T-score

  

0.221 ± 0.077

0.014

LS BMD

  

0.024 ± 0.008

0.014

rs2234693:T > C genotypes

CC

FN T-score

−2.124 ± 0.093

−1.518 ± 0.072

0.606 ± 0.081

0.001

 

FN BMD

0.603 ± 0.011

0.676 ± 0.09

0.073 ± 0.010 (+ 12.6%)

0.001

 

TC

FN T-score

−2.139 ± 0.064

−1.772 ± 0.049

0.367 ± 0.058

0.001

 

FN BMD

0.601 ± 0.008

0.645 ± 0.006

0.044 ± 0.007 (+ 7.7%)

0.001

 

TT

FN T-score

−2.132 ± 0.088

−2.000 ± 0.068

0.132 ± 0.077

NS

 

FN BMD

0.602 ± 0.011

0.618 ± 0.008

0.016 ± 0.009 (+ 3.0%)

NS

 

CC-TC

FN T-score

   

NS for FN T-score and FN BMD

 

FN BMD

    

CC-TT

FN T-score

    

FN BMD

    

TC-TT

FN T-score

    

FN BMD

    

CC

LS T-score

−2.894 ± 0.095

−1.818 ± 0.079

1.077 ± 0.067

0.001

 

LS BMD

0.673 ± 0.010

0.789 ± 0.008

0.115 ± 0.007 (+ 17.4%)

0.001

 

TC

LS T-score

−2.844 ± 0.065

−2.147 ± 0.054

0.697 ± 0.064

0.001

 

LS BMD

0.679 ± 0.007

0.753 ± 0.006

0.075 ± 0.007 (+ 11.2%)

0.001

 

TT

LS T-score

−2.921 ± 0.090

− 2.500 ± 0.075

0.421 ± 0.146

0.010

 

LS BMD

0.670 ± 0.010

0.715 ± 0.008

0.045 ± 0.016 (+ 7.6%)

0.010

 

CC-TC

LS T-score

  

0.140 ± 0.083

0.001 for FN T-score and FN BMD

NS

LS BMD

  

0.015 ± 0.009

NS

CC-TT

LS T-score

  

0.354 ± 0.094

0.001

LS BMD

  

0.038 ± 0.010

0.001

TC-TT

LS T-score

  

0.215 ± 0.080

0.026

LS BMD

  

0.023 ± 0.009

0.026

  1. BMD of femoral neck (FN) and lumbal spine (LS) is expressed as Estimated Marginal Mean ± SE (SE – standard error of the mean) of T-score (FN and LS T-score) and g/cm2 (FN and LS BMD), GLM Sig. – significance of GLM, PC Sig. – significance of pairwise comparisons, NS – non-significant GLM/BMD differences, P values determine significant BMD differences (P < 0.05)